Thus, the data suggest that ICG-001, by switching beta-catenin binding from CBP to p300, downregulates CBP-dependent Wnt signaling, resulting in enhanced CRC apoptosis. This evidence concerns the gene CTNNB1 and colorectal carcinoma.